These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10622548

  • 1. Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.
    Svanegaard J, Johansen JB, Klitgaard NA, Thayssen P, Haghfelt T.
    Scand Cardiovasc J; 1999; 33(6):355-61. PubMed ID: 10622548
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE, St John Sutton MG, Froeland GS, Holme I, Skjaerpe T, Hall C.
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [Abstract] [Full Text] [Related]

  • 3. N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.
    Hole T, Hall C, Skaerpe T.
    Eur Heart J; 2004 Mar; 25(5):416-23. PubMed ID: 15033254
    [Abstract] [Full Text] [Related]

  • 4. Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction.
    Górecki A, Januszewicz A, Opolski G, Lapiński M, Wocial B, Ignatowska-Switalska H, Słomka K, Kochanowski J, Stolarz P.
    J Cardiovasc Risk; 1995 Feb; 2(1):45-50. PubMed ID: 7606640
    [Abstract] [Full Text] [Related]

  • 5. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
    van der Vekens N, Decloedt A, de Clercq D, Ven S, Sys S, van Loon G.
    Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480
    [Abstract] [Full Text] [Related]

  • 6. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.
    Kettunen RV, Leppäluoto J, Jounela A, Vuolteenaho O.
    Am Heart J; 1994 Jun; 127(6):1449-55. PubMed ID: 8197967
    [Abstract] [Full Text] [Related]

  • 7. Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.
    McKie PM, Cataliotti A, Sangaralingham SJ, Ichiki T, Cannone V, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC.
    Mayo Clin Proc; 2011 Dec; 86(12):1154-60. PubMed ID: 22134933
    [Abstract] [Full Text] [Related]

  • 8. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
    Ikeda N, Yasu T, Nishikimi T, Nakamura T, Kubo N, Kawakami M, Momomura S, Saito M.
    Regul Pept; 2007 Jun 07; 141(1-3):154-8. PubMed ID: 17292492
    [Abstract] [Full Text] [Related]

  • 9. Association Between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical Substrate and NT-proANP Levels in Atrial Fibrillation.
    Seewöster T, Büttner P, Nedios S, Sommer P, Dagres N, Schumacher K, Bollmann A, Hilbert S, Jahnke C, Paetsch I, Hindricks G, Kornej J.
    J Am Heart Assoc; 2018 Oct 02; 7(19):e009427. PubMed ID: 30371296
    [Abstract] [Full Text] [Related]

  • 10. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL.
    J Am Coll Cardiol; 2008 May 13; 51(19):1857-64. PubMed ID: 18466800
    [Abstract] [Full Text] [Related]

  • 11. N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.
    Brueckmann M, Bertsch T, Hoffmann U, Lang S, Kaden JJ, Wolpert C, Huhle G, Borggrefe M, Haase KK.
    Clin Chem Lab Med; 2004 May 13; 42(8):896-902. PubMed ID: 15387439
    [Abstract] [Full Text] [Related]

  • 12. Natriuretic peptides in patients with aortic stenosis.
    Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, Hall C.
    Am Heart J; 2001 Oct 13; 142(4):725-32. PubMed ID: 11579366
    [Abstract] [Full Text] [Related]

  • 13. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R, Iordanova N, Jarai R, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K.
    Eur Heart J; 2005 Feb 13; 26(3):250-6. PubMed ID: 15618049
    [Abstract] [Full Text] [Related]

  • 14. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P, Schumacher K, Dinov B, Zeynalova S, Sommer P, Bollmann A, Husser D, Hindricks G, Kornej J.
    Heart Rhythm; 2018 Aug 13; 15(8):1132-1137. PubMed ID: 29604419
    [Abstract] [Full Text] [Related]

  • 15. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction.
    Uusimaa P, Ruskoaho H, Vuolteenaho O, Niemelä M, Lumme J, Ikäheimo M, Jounela A, Peuhkurinen K.
    Int J Cardiol; 1999 Apr 30; 69(1):5-14. PubMed ID: 10362366
    [Abstract] [Full Text] [Related]

  • 16. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, Vuolteenaho O, Hartikainen J.
    J Intern Med; 2002 Mar 30; 251(3):228-34. PubMed ID: 11886482
    [Abstract] [Full Text] [Related]

  • 17. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
    Hystad ME, Geiran OR, Attramadal H, Spurkland A, Vege A, Simonsen S, Hall C.
    Acta Physiol Scand; 2001 Apr 30; 171(4):395-403. PubMed ID: 11421854
    [Abstract] [Full Text] [Related]

  • 18. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, Sundsfjord JA, Dickstein K.
    Circulation; 1996 Jun 01; 93(11):1963-9. PubMed ID: 8640969
    [Abstract] [Full Text] [Related]

  • 19. Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction.
    Bacaksiz A, Vatankulu MA, Kayrak M, Telli HH, Ayhan SS, Sonmez O, Alp A, Buyukbas S.
    Clinics (Sao Paulo); 2013 Jul 01; 68(7):997-1003. PubMed ID: 23917666
    [Abstract] [Full Text] [Related]

  • 20. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
    Ala-Kopsala M, Magga J, Peuhkurinen K, Leipälä J, Ruskoaho H, Leppäluoto J, Vuolteenaho O.
    Clin Chem; 2004 Sep 01; 50(9):1576-88. PubMed ID: 15265819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.